Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 25 ... with congenital abnormalities, penile cancer, traumatic injury and some cases of erectile dysfunction will benefit from this technology in the future."Reconstructing damaged or ...
Subject: Wake Forest University Baptist Medical Center
2009 NOV 16 ... two, phase III trials for udenafil, a new long acting drug under development for erectile dysfunction (ED). Each randomized, double-blind, placebo-controlled trial is designed to evaluate ...
2009 NOV 16 ... ESAI's ultimate goal is the use of the drug to provide long-term correction of male erectile dysfunction in an aged population, as well as in patients with diabetes and those who have undergone ...
2009 NOV 27 ... therapists and medical professionals for its potential in working with issues such as erectile dysfunction and physical rehabilitation.The device only works with specifically encoded ...
2009 NOV 10 ... penile prosthesis (IPP) is a well-established treatment for medically refractory erectile dysfunction with proven long-term reliability. However, if an IPP fails, the subsequent surgery to ...
2009 NOV 23 ... observed in men differed before and after the introduction of sildenafil, the first oral erectile dysfunction medication approved by the Food and Drug Administration. We used Cox proportional ...
2009 NOV 16 ... in addition, a pilot study utilizing saffron has indicated a positive effect on men with erectile dysfunction. "The world has used saffron for over 3,000 years as a healing substance ...
2009 NOV 23 ... stage terbinafine treatment for onychomycosis, a late stage alprostadil treatment for erectile dysfunction, a P 2 alprostadil treatment for female sexual arousal disorder, and an early stage ...
2009 NOV 16 ... (p=0.0189) were demonstrated to be statistically significant variables. Postoperative erectile dysfunction was noted in 33 out of 114 (28.9%) patients who were preoperatively potent," wrote T. ...
2009 NOV 16 ... Data detailed in 'Nerve injury-related erectile dysfunction following nerve-sparing radical prostatectomy: a novel experimental dissection model' ...
2009 NOV 9 ... in 21 countries from November 2002 to May 2004 were used in this analysis. Men with erectile dysfunction and a history of >= 6-week prior sildenafil citrate use continued sildenafil citrate ...
2009 NOV 9 ... "Orally active phosphodiesterase type 5 inhibitors (PDE5i), used in the treatment of erectile dysfunction, facilitate the relaxation of cavernous smooth muscle tissues by reducing the ...
2009 NOV 10 ... According to recent research published in the Journal of Sexual Medicine, "Erectile dysfunction (ED) may be regarded as a shared sexual concern with a significant negative impact on ...
2009 NOV 16 ... for instance, was once intended for coronary heart disease but now is used to combat erectile dysfunction. The discovery of surprising uses of developed drugs can sometimes be the result of ...
2009 NOV 13 ... of patients undergoing dynamic infusion cavernosometry (DIC) in the evaluation of erectile dysfunction or prior to penile reconstructive surgery. DIC was conducted with a standard vasoactive ...
2009 NOV 23 ... The study found that the workers in the BPA facilities had quadruple the risk of erectile dysfunction, and seven times more risk of ejaculation difficulty. This is the first ...
